Efficacy News and Research

RSS
Biovest seeks Health Canada approval of BiovaxID for follicular NHL

Biovest seeks Health Canada approval of BiovaxID for follicular NHL

OphthaliX completes CF101 preclinical studies on Anterior Uveitis

OphthaliX completes CF101 preclinical studies on Anterior Uveitis

Novel anti-leukemia compound with little toxicity successfully treats zebrafish

Novel anti-leukemia compound with little toxicity successfully treats zebrafish

Delivering chemotherapy drugs with nanobubbles more deadly to cancer cells

Delivering chemotherapy drugs with nanobubbles more deadly to cancer cells

Bioness commences StimRouter Neuromodulation System study for chronic peripheral nerve pain

Bioness commences StimRouter Neuromodulation System study for chronic peripheral nerve pain

MD Anderson initiates Phase 1/2 entinostat-lapatinib ditosylate combination study in metastatic breast cancer

MD Anderson initiates Phase 1/2 entinostat-lapatinib ditosylate combination study in metastatic breast cancer

Ampio submits pre-IND package on Zertane to FDA

Ampio submits pre-IND package on Zertane to FDA

Scientists identify how Clec9A protein recognises foreign invaders

Scientists identify how Clec9A protein recognises foreign invaders

Tonix completes TNX-102 pharmacokinetic study on fibromyalgia syndrome

Tonix completes TNX-102 pharmacokinetic study on fibromyalgia syndrome

Sucampo announces positive results from lubiprostone phase 3 trial on OBD

Sucampo announces positive results from lubiprostone phase 3 trial on OBD

BIND announces data from BIND-014 Phase 1 trials on prostate cancer

BIND announces data from BIND-014 Phase 1 trials on prostate cancer

Viewpoints: Obama's 'diatribe' on Ryan budget; President 'recovers' on statements about the court; Other health care mandates

Viewpoints: Obama's 'diatribe' on Ryan budget; President 'recovers' on statements about the court; Other health care mandates

BIND presents results from BIND-014 Phase 1 trial on solid tumors at AACR 2012

BIND presents results from BIND-014 Phase 1 trial on solid tumors at AACR 2012

Ventria completes VEN100 phase 2 trial on antibiotic-associated diarrhea

Ventria completes VEN100 phase 2 trial on antibiotic-associated diarrhea

µ-PIIIA conotoxin can be effective in controlling cancer pain

µ-PIIIA conotoxin can be effective in controlling cancer pain

Combination treatment shows promise against NSCLC patients ineligible for bevacizumab

Combination treatment shows promise against NSCLC patients ineligible for bevacizumab

Positive preclinical results from Cancer Therapeutics' CTX-0294945 plus Avastin study

Positive preclinical results from Cancer Therapeutics' CTX-0294945 plus Avastin study

Nuvilex realizes important role for Cell-in-a-Box technology

Nuvilex realizes important role for Cell-in-a-Box technology

Navidea announces FDA extension of Lymphoseek PDUFA date by three months

Navidea announces FDA extension of Lymphoseek PDUFA date by three months

Lilly announces results of three preclinical studies that focus on c-MET receptor

Lilly announces results of three preclinical studies that focus on c-MET receptor

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.